ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2022

HLA class II immunogenic mutation burden predicts response to immune checkpoint blockade.

X M Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.